Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patients
A legfontosabb adatok
- Ki végzi
- Henry Ford Health System
- Hol
- Detroit (Egyesült Államok)A helyszín megnézése
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 268 fő, tervezett
- Kezdés
- 2026. jan. 28.
- Várható befejezés
- 2030. febr.
- A vizsgálat típusa
- Beavatkozással járó, 6 csoport
- A vizsgált kezelések
- ENGAGE-ALD Application (APP)
- Treatment Facilitation bundle
- Enhanced Usual Care
- A regiszteradat frissítve
- 2026. február 3.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for adults with alcohol-related liver disease who drank alcohol in the past 6 months. They must not have had alcohol use treatment in the past 1 month. Participants are seen at University of Michigan hepatology clinics or are patients in UM Hospitals.
- Életkor
- 18 Years and older
- Nem
- All
- A betegség stádiuma
- A documented diagnosis of alcohol-related liver disease (ALD). Any amount of alcohol use within the past 6 months.
- Korábbi kezelés
- No alcohol use treatment in the past 1 month. This includes counseling, recovery groups such as Alcoholics Anonymous, church support groups, inpatient or intensive outpatient programs, and telehealth versions of these.
- Biomarker vagy leletérték
- Recent alcohol use can be shown by a positive alcohol test in the medical record, such as blood alcohol level, urinary ethyl glucuronide, urinary ethyl sulfate, or phosphatidylethanol. Interview or chart review also counts.
A részvétel fő kizáró okai
- Serious thinking problems, such as Westhaven grade 2 or higher hepatic encephalopathy (brain changes from liver disease) or a Short Blessed Test score >=10
- Being evaluated for, listed for, or already having had a liver transplant
- Unable to read, speak or understand English
- Already enrolled in the multidisciplinary ALD clinic at Michigan Medicine
- Past history of not following the rules of earlier clinical or research studies
A regiszter feltételei, szó szerint
Mind a 15 feltétel megnézéseKevesebb
Ki vehet részt
- Willingness to comply with all study procedures and availability for the duration of the study
- Willing and able to provide informed consent
- Enrolled at University of Michigan (UM) hepatology clinics or inpatients at UM Hospitals
- Documented diagnosis of alcohol-related liver disease (ALD) (per protocol)
- Recent alcohol use of any amount within the past 6 months as assessed by either patient interview, medical chart review, or positive alcohol biomarker (e.g. blood alcohol level, urinary ethyl glucuronide, urinary ethyl sulfate, or phosphatidylethanol) in the medical record
- No alcohol use treatment within the past 1 month including, but not limited to:; Any professionally lead therapy with a mental health counselor (such as, one-on-one therapy, group therapy, couples or family therapy) with a primary aim of alcohol abstinence or reduction in alcohol use; Community-based alcohol recovery groups (such as, Alcoholics Anonymous, SMART Recovery, Celebrate Recovery, Refuge Recovery); Community-based church support groups primarily focused on alcohol abstinence or reduction in use; Residential (inpatient) alcohol treatment; Intensive outpatient programs; Any telehealth version of the above options
- Access to a Smartphone or computer for purposes of follow-up. Those who do not have a Smartphone will be provided one along with a calling/data plan at no cost to subject by the study team for the duration of the research stud
- Ability to speak and comprehend English
Ki nem vehet részt
- Undergoing active evaluation for liver transplantation, is listed for liver transplant, or is post-transplantation
- History of nonadherence to previous clinical or research studies
- Substantially cognitively impaired as evidenced by Westhaven grade 2 or higher hepatic encephalopathy or a score >=10 on the Short Blessed Test for cognitive impairment
- Any other medical condition or circumstance that precludes safe and meaningful participation in the study
- Unable to provide voluntary informed consent for any reason
- Unable to read or understand English
- Is enrolled in the multidisciplinary ALD clinic at Michigan Medicine
Helyszínek itt: Egyesült Államok
- Henry Ford HealthDetroit, Egyesült ÁllamokContact: Matthew MelicanRésztvevőt keres
A vizsgálatról
Mit akar kideríteni a vizsgálat
The purpose of this trial is to see if providing patients with alcohol-related liver disease with tailored alcohol use treatment options will increase engagement with treatment and correct possible misconceptions.
A vizsgálat 6 csoportja
- Enhanced usual care (EUC)A vizsgált kezelés
Eligible participants randomized will be given this for stage 1 of treatment (three months) and stage 2 (three months) if participants engaged in alcohol treatment during the first stage of treatment.
Kezelés: Enhanced Usual Care
- ENGAGE-ALD application (app)A vizsgált kezelés
Eligible participants randomized to this arm will be given this for stage 1 (three months) of treatment and stage 2 (three months) if participants engaged in alcohol treatment during the first stage of treatment.
- ENGAGE-ALD app then Treatment Facilitation BundleA vizsgált kezelés
Eligible participants randomized to this arm will be given this for stage 1 of treatment (three months). Participants that are non-responders (did not engage in alcohol treatment) will be re-randomized and assigned to the Treatment Facilitation bundle for stage 2 (three months).
Kezelés: ENGAGE-ALD Application (APP) és Treatment Facilitation bundle
- Enhanced usual care then Treatment Facilitation BundleA vizsgált kezelés
Eligible participants randomized to this arm will be given this for stage 1 of treatment (three months). Participants that are non-responders (did not engage in alcohol treatment) will be re-randomized and assigned to the Treatment Facilitation bundle for stage 2 (three months).
Kezelés: Treatment Facilitation bundle és Enhanced Usual Care
- ENGAGE-ALD app then Enhanced usual careA vizsgált kezelés
Eligible participants randomized to this arm will be given this for stage 1 (three months) of treatment. Participants that are non-responders (did not engage in alcohol treatment) will be re-randomized to the EUC arm stage 2 (three months).
Kezelés: ENGAGE-ALD Application (APP)
- Enhanced usual care then Enhanced usual careA vizsgált kezelés
Eligible participants randomized to this arm will be given this for stage 1 of treatment (three months). Participants that are non-responders (did not engage in alcohol treatment) will be rerandomized to the Enhanced usual care arm stage 2 (three months).
Kezelés: Enhanced Usual Care
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Enhancing Alcohol Treatment Engagement in ALD Patients
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- A regiszteradat frissítve
- 2026. február 3.